Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 306

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 306
---
.

F-17

Net Loss per Common Share

Net Loss per Common Share is computed by dividing
net loss attributable to common shareholders by the weighted average number of common shares outstanding during each period. The Company
has included the Pre-Funded Warrants issued in January 2024 and September 2024 (See Note 6) in its computation of basic and diluted net
loss per share due to their nominal exercise prices. The cumulative dividends accrued on the Series A Preferred Stock during the period
are reflected as an addition to net loss in determining basic and diluted net loss attributable to common stockholders.

As the Company has reported a net loss for all
periods presented, the calculation of diluted net loss per common share is the same as basic net loss per common share for those periods.

As a result of the Reverse Stock Splits, which
were effective as of August 12, 2024 at a ratio of 1:12 and February 24, 2025 at a ratio of 1:5, all shares of outstanding common stock
and net loss per common share calculations have been retroactively adjusted for all periods presented.

Related Parties

Parties are considered to be related to the Company
if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with
the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal
owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly
influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from
fully pursuing its own separate interests.

Subsequent Events

The Company considers events or transactions
that occur after the balance sheet date, but prior to the issuance of the financial statements to provide additional evidence relative
to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated through March 27,
2025, which is the date the financial statements were issued. See Note 12.

Recently Adopted and Issued Accounting Pronouncements

From time to time, the FASB issues Accounting
Standards Updates (“ASU”) to amend the authoritative literature in the ASC. The Company regularly evaluates new ASUs to determine
the impact that these pronouncements may have on the consolidated financial statements. Other than the pronouncements listed below, the
Company believes that those issued to date either (i